Is GHB (Gamma-hydroxybutyrate) safe for babies and kids?
Very high risk for kidsInfants are more vulnerable to GHB (Gamma-hydroxybutyrate) than children or adults due to immature hepatic/renal clearance, higher intake-to-body-weight ratio, rapid organ development, and increased gastrointestinal absorption.
What is ghb (gamma-hydroxybutyrate)?
The IUPAC name is 4-hydroxybutanoic acid.
Also known as: 4-hydroxybutanoic acid, 4-Hydroxybutyric acid, gamma-Hydroxybutyric acid, 4-hydroxy-butyric acid.
- IUPAC name
- 4-hydroxybutanoic acid
- CAS number
- 591-81-1
- Molecular formula
- C4H8O3
- Molecular weight
- 104.1 g/mol
- SMILES
- C(CC(=O)O)CO
- PubChem CID
- 10413
Risk for babies
Very high riskInfants are more vulnerable to GHB (Gamma-hydroxybutyrate) than children or adults due to immature hepatic/renal clearance, higher intake-to-body-weight ratio, rapid organ development, and increased gastrointestinal absorption.
Neonates and infants up to 12 months have incomplete blood-brain barrier development, immature Phase I/II metabolic enzymes (particularly CYP3A4, UGT1A1), and higher gastrointestinal permeability. Equivalent doses produce higher internal concentrations and longer residence times.
Risk for pregnant and nursing people
Context-dependentPregnancy alters the metabolism and distribution of GHB (Gamma-hydroxybutyrate), potentially increasing fetal exposure. The developing embryo/fetus is vulnerable during organogenesis (weeks 3-8) and neurological development. Placental transfer should be assumed.
No specific reproductive toxicity data identified, but pregnancy-specific safety data is limited for most chemicals. Precautionary minimization of exposure is recommended.
Regulatory consensus
2 regulatory and scientific bodies have classified GHB (Gamma-hydroxybutyrate). The classifications differ — that's the data.
| Agency | Year | Classification | Notes |
|---|---|---|---|
| DEA | — | Schedule I substance (when used illicitly) | |
| FDA | — | Schedule III FDA-approved medication | Approved as Xyrem®/Lumryz® (sodium oxybate) for narcolepsy with cataplexy; requires REMS program |
Regulators apply different standards of evidence — animal-data weighting, exposure-pattern assumptions, epidemiological power thresholds — which is why two scientific bodies can review the same data and reach different conclusions. The disagreement is the data.
Where kids encounter ghb (gamma-hydroxybutyrate)
- Industrial Facilities — Manufacturing plants, Chemical storage areas, Waste treatment sites
- Occupational Environments — Factories, Warehouses, Transportation vehicles
Safer alternatives
Lower-risk approaches that achieve a similar outcome to GHB (Gamma-hydroxybutyrate):
-
Cessation / treatment programs
Trade-offs: Removes 95-99% of dissolved contaminants including metals, PFAS, nitrates; wastes 2-4 gallons per gallon produced (improving with newer systems); removes beneficial minerals; $0.05-0.25/gallon; requires pre-treatment for longevity.Relative cost: 1.2-2×
Frequently asked questions
Is ghb (gamma-hydroxybutyrate) safe for kids?
Infants are more vulnerable to GHB (Gamma-hydroxybutyrate) than children or adults due to immature hepatic/renal clearance, higher intake-to-body-weight ratio, rapid organ development, and increased gastrointestinal absorption.
What products contain ghb (gamma-hydroxybutyrate)?
GHB (Gamma-hydroxybutyrate) appears in: Manufacturing plants (Industrial facilities); Chemical storage areas (Industrial facilities); Factories (Occupational environments); Warehouses (Occupational environments).
What should I do if my child is exposed to ghb (gamma-hydroxybutyrate)?
Minimize infant exposure through source control. For breastfeeding mothers: reduce maternal exposure. For formula-fed infants: use certified low-migration bottles and verified water sources. Consult pediatrician regarding any concerns.
See GHB (Gamma-hydroxybutyrate) in the baby app
Look up products containing ghb (gamma-hydroxybutyrate), compare to alternatives, and explore the full data record.
Open in baby View raw API dataSources (2)
- US DEA: GHB (Gamma-Hydroxybutyrate) — Dual Scheduling (Schedule I Illicit/Schedule III as Xyrem), Drug-Facilitated Sexual Assault, Narrow Therapeutic Index, Alcohol Synergy, DFSA Detection Window, and Physical Dependence with Withdrawal (2022) (2022) — regulatory
- US FDA: Sodium Oxybate (Xyrem/Lumryz) — Narcolepsy Approval, REMS Program for Abuse Mitigation, Pediatric Indication (Age 7+ Years), and GHB Chemical Identity with Illicit GHB (2022) (2022) — regulatory
Reference data, not professional advice. Aggregates publicly available regulatory and scientific data; not a substitute for veterinary, medical, legal, or regulatory advice. Why we built ALETHEIA →